Boston Scientific Corporation’s $435 Million Acquisition of Symetis SA

Latham & Watkins, KLA-Koury Lopes Advogados, Leoni Siqueira and Lobo de Rizzo have advised on the deal

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices.

With the completion of the acquisition, Boston Scientific will immediately begin selling the ACURATE TA™ and ACURATE neo™/TF™ valve* systems in Europe and in other geographies outside of the United States, and Symetis will become part of the Boston Scientific Interventional Cardiology division.

The two organizations announced a definitive agreement on March 30, 2017 for Boston Scientific to acquire the Symetis business for $435 million in cash.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company, led by Michael F. Mahoney, Daniel J. Brennan, Edward F. Mackey, Joseph M. Fitzgerald and Kevin J. Ballinger, is based in Marlborough (MA).

Symetis SA, a medical technology company, engages in the development, manufacturing, and marketing of transcatheter aortic valve implantation (TAVI) devices for minimally invasive heart valve replacement in Switzerland, Germany, Austria, and internationally. The company, led by Jacques R. Essinger, Khaled Bahi, Francis Jannot and Stéphane Delaloye, is based in Switzerland.

Latham & Watkins LLP has advised Boston Scientific Corporation with Julie Scallen (Picture), Nicholas DeNovio, Johan Brigham, Sean Fitzgerald, Stefanie Vincent, John Joy and Jared Grimley.

In Brazil, KLA-Koury Lopes has advised Boston Scientific Corporation with Alexandre Pessoa, Karin Alvo, Patricia Braga and Mayara Ruano.

Leoni Siqueira has advised Symetis S.A. with Flavio Leoni Siqueira, Felipe Torres and Fernanda Soeiro.

Lobo de Rizzo has advised Labcor Laboratórios Ltda. – holding a minority stake in Symetis SA – with Rodrigo Roso, Valdo Cestari de Rizzo and Nicolle Zennaro.

Involved fees earner: Felipe de Assis Torres – Leoni Siqueira; Flavio Leoni Siqueira – Leoni Siqueira; Fernanda Soeiro de Britto – Leoni Siqueira; Rodrigo Roso – Lobo & de Rizzo; Valdo Cestari de Rizzo – Lobo & de Rizzo; Nicolle Zennaro – Lobo & de Rizzo; Karin Alvo – KLA – Koury Lopes Advogados; Patricia Braga – KLA – Koury Lopes Advogados; Alexandre Pessoa – KLA – Koury Lopes Advogados; Julie Scallen – Latham & Watkins; Johan Brigham – Latham & Watkins; John Joy – Latham & Watkins; Nicholas DeNovio – Latham & Watkins; Sean FitzGerald – Latham & Watkins; Jared Grimley – Latham & Watkins;

Law Firms: Leoni Siqueira; Lobo & de Rizzo; KLA – Koury Lopes Advogados; Latham & Watkins;

Clients: Boston Scientific; Symetis; Labcor Laboratórios Ltda.;

Print Friendly, PDF & Email

Author: Ambrogio Visconti